BLUE BELL, Pa., April 29, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the company will make presentations at three investor conferences:

JMP Securities Research Conference

San Francisco, CA, May 9-11, 2011

The Ritz-Carlton, San Francisco

Inovio Presentation

Dr. J. Joseph Kim, Ph.D., President & CEO

May 9, 2011

10:30 AM

MDB Bright Lights Conference

New York, NY, May 10-11, 2011

Le Parker Meridien Hotel

Inovio Presentation

Thomas Kim, VP, IP and Associate General Counsel

May 11, 2011

10:00 AM

Bright Lights is an investment conference focused on publicly traded companies with disruptive and market changing intellectual property (IP). Inovio was selected from MDB's 2011 group of "Best and Brightest" small-cap companies; a group that is advancing some of today's most innovative and market-leading IP.  Inovio is one of the 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by PatentVest, MDB's proprietary IP business intelligence platform.

Noble Financial Investor Conference

Hollywood, FL, May 16-17, 2011

Hard Rock Hotel

Inovio Presentation

Dr. J. Joseph Kim, Ph.D., President & CEO

May 16, 2011

2:00 PM